borderline significantP =0.05
pylori antibodies was significantly higher in the group of patients with colorectal cancer than the healthy controls; however, the difference was only borderline significant ( P =0.05).
pylori antibodies was significantly higher in the group of patients with colorectal cancer than the healthy controls; however, the difference was only borderline significant ( P =0.05).